American College of Clinical Pharmacy
      Search      Cart
         
ACCP Report

Pharmacotherapy Pearls

Annual Call for Pharmacotherapy Reviewers

Written by Wendy R. Cramer, B.S., FASCP; Richard T. Scheife, Pharm.D., FCCP

Pharmacotherapy Pearls

The value of the academic reviewer in all quality bioscience publications cannot be overstated. Only someone who is actively involved in and has a passion for clinical practice or research can accurately assess the scientific rigor and impact of a given manuscript submitted for publication. So, how does one make the leap from an impassioned pharmacy clinician or researcher to an academic reviewer?

If you would like to become a reviewer, you may do so online. Simply go to the Manuscript Central Web site (Pharmacotherapy’s online manuscript management system) at http://mc.manuscriptcentral.com/pharmacotherapy. Then, proceed to “create account” at the top right-hand portion of the page, and follow the step-by-step directions. You will be prompted to provide contact information, and you will be able to specify your areas of expertise (you may choose one or several) from a list of more than 100 specialty areas. These categories are as follows:

  • ACE inhibitors
  • Acute coronary syndrome
  • ADHD
  • Administration
  • Adverse drug reactions
  • AIDS
  • Allergy
  • Alzheimer’s disease
  • Ambulatory
  • Aminoglycosides
  • Analgesia
  • Anemias
  • Anesthesiology
  • Anticoagulation
  • Antiepileptic drugs
  • Antifungals
  • Anti-inflammatories
  • Antiplatelets
  • Antiretrovirals
  • Antivirals
  • Anxiety
  • ARDS
  • Arrhythmias
  • Arthritis
  • Asthma
  • Bacterial resistance
  • Biotechnology
  • Bioterrorism
  • Bipolar
  • Botulism
  • Breastfeeding
  • Burns
  • C-reactive protein
  • CAD
  • Cardiology
  • COPD
  • Community practice
  • Complementary and alternative medicine
  • Computer technology
  • Contraception
  • Critical care
  • Cytochrome P450
  • Dementia
  • Depression
  • Dermatology
  • Diabetes
  • Dialysis
  • Drug abuse
  • Drug information
  • Drug safety
  • Endocrinology
  • Epidemiology
  • Ethics
  • Evidence-based medicine
  • Febrile neutropenia
  • Fluids and electrolytes
  • Fluoroquinolones
  • Forensic medicine
  • Gastroenterology
  • Geriatrics
  • Glaucoma
  • Gout
  • Headache
  • Heart failure
  • Hematology
  • Hospice
  • Hypertension
  • Immunizations
  • Immunology
  • Industry
  • Infectious disease
  • Insomnia
  • Legal
  • Lipids
  • Liver
  • Lyme disease
  • Managed care
  • Migraine
  • Nausea
  • Neonatology
  • Neurology
  • Neuromuscular-blocking agents
  • Neuropathy
  • Neurosurgery
  • Nuclear medicine
  • Nutrition
  • Obesity
  • Oncology
  • Ophthalmology
  • Outcomes
  • Parkinson’s disease
  • Patient safety
  • Pediatrics
  • Peptic ulcer disease
  • Pharmacodynamics
  • Pharmacoeconomics
  • Pharmacogenomics
  • Pharmacokinetics
  • Pharmacology
  • Pharmacy education
  • Pharmacy practice
  • Pregnancy
  • Psychiatry
  • Public health
  • Pulmonary
  • Quality of life
  • Renal
  • Restless leg syndrome
  • Septic shock
  • Sickle cell
  • Smoking cessation
  • Spinal cord and brain injury
  • Statistics
  • Stereoisomers
  • Steroids
  • Stroke
  • Study design
  • Surgery
  • Thrombocytopenias
  • Thyroid
  • Toxicology
  • Transplant
  • Travel medicine
  • Urology
  • Vancomycin
  • Women’s health

We would like to thank all of you who have served the journal as reviewers as well as those of you who are interested in becoming reviewers.